Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences

Schizophrenia Research

Volumn 157, Issue 1-3, 2014, Pages 266-270

  van Gastel, W A ^a,b,d   Vreeker, A ^a   Schubart, C D ^a,b   MacCabe, J H ^c   Kahn, R S ^a   Boks, M P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c TERGOOI HOSPITAL   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; Psychosis; Psychotic experience; Risk

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS USE; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES; DEPRESSION; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POPULATION; POSITIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; YOUNG ADULT; ADOLESCENT; CANNABIS SMOKING; MARIJUANA ABUSE; NETHERLANDS; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NETHERLANDS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84904091771     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.04.023     Document Type: Article

References (41)

1. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
2. Bossong M.G., Niesink R.J. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog. Neurobiol. 2010, 92:370-385.
3. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
4. Chapman L.J., Chapman J.P., Kwapil T.R., Eckblad M., Zinser M.C. Putatively psychosis-prone subjects 10years later. J. Abnorm. Psychol. 1994, 103:171-183.
5. Chaves S.S., Gargiullo P., Zhang J.X., Civen R., Guris D., Mascola L., Seward J.F. Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med. 2007, 356:1121-1129.
6. Costas J., Sanjuan J., Ramos-Rios R., Paz E., Agra S., Tolosa A., Paramo M., Brenlla J., Arrojo M. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr. Res. 2011, 127:22-27.
7. Cougnard A., Marcelis M., Myin-Germeys I., De Graaf R., Vollebergh W., Krabbendam L., Lieb R., Wittchen H.U., Henquet C., Spauwen J., Van Os J. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol. Med. 2007, 37:513-527.
8. Fergusson D.M., Horwood L.J., Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Psychol. Med. 2003, 33:15-21.
9. Genetic Risk and Outcome in Psychosis (GROUP) investigators Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch. Gen. Psychiatry 2011, 68:138-147.
10. Greenland S. Modeling and variable selection in epidemiologic analysis. Am. J. Public Health 1989, 79:340-349.
11. Hanssen M., Bak M., Bijl R., Vollebergh W., Van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br. J. Clin. Psychol. 2005, 44:181-191.
12. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., Van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330:11.
13. Johns L.C., Van Os J. The continuity of psychotic experiences in the general population. Clin. Psychol. Rev. 2001, 21:1125-1141.
14. Konings M., Bak M., Hanssen M., Van Os J., Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr. Scand. 2006, 114:55-61.
15. Kuepper R., Van Os J., Lieb R., Wittchen H.U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10year follow-up cohort study. BMJ 2011, 342:d738.
16. Lee S.S., Humphreys K.L., Flory K., Liu R., Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin. Psychol. Rev. 2011, 31:328-341.
17. Macleod J. Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al. Psychol. Med. 2007, 37:913-916.
18. Macleod J., Hickman M. Commentary: understanding pathways to cannabis use and from use to harm. Int. J. Epidemiol. 2006, 35:680-682.
19. Macleod J., Davey S.G., Hickman M. Does cannabis use cause schizophrenia?. Lancet 2006, 367:1055.
20. Macleod J., Davey S.G., Hickman M., Egger M. Cannabis and psychosis. Lancet 2007, 370:1539-1540.
21. Malcolm C.P., Picchioni M.M., DiForti M., Sugranyes G., Cooke E., Joseph C., McQueen G., Paparelli A., Stilo S., O'Connor J., Morgan C., Murray R.M., Hodgins S. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis. Schizophr. Res. 2011, 126:81-86.
22. Meyerson P., Tryon W.W. Validating internet research: a test of the psychometric equivalence of internet and in-person samples. Behav. Res. Methods Instrum. Comput. 2003, 35:614-620.
23. Monshouwer K., Van Dorsselaer S., Verdurmen J., Bogt T.T., De Graaf R., Vollebergh W. Cannabis use and mental health in secondary school children. Findings from a Dutch survey. Br. J. Psychiatry 2006, 188:148-153.
24. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
25. Mullin K., Gupta P., Compton M.T., Nielssen O., Harris A., Large M. Does giving up substance use work for patients with psychosis? A systematic meta-analysis. Aust. N. Z. J. Psychiatry 2012, 46:826-839.
26. Murray R.M., Morrison P.D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 2007, 8:885-895.
27. Niesink R., Rigter S., Hoek J., den Boer N. THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops 2009, Trimbos Institute, The Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
28. Peters E.R., Joseph S.A., Garety P.A. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr. Bull. 1999, 25:553-576.
29. R Development Core Team R: a Language and Environment for Statistical Computing http://www.R-project.org.
30. Schubart C.D., van Gastel W.A., Breetvelt E.J., Beetz S.L., Ophoff R.A., Sommer I.E., Kahn R.S., Boks M.P. Cannabis use at a young age is associated with psychotic experiences. Psychol. Med. 2011, 41:1301-1310.
31. Stefanis N.C., Hanssen M., Smirnis N.K., Avramopoulos D.A., Evdokimidis I.K., Stefanis C.N., Verdoux H., Van Os J. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol. Med. 2002, 32:347-358.
32. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341.
33. van Gastel W.A., Wigman J.T., Monshouwer K., Kahn R.S., Van Os J., Boks M.P., Vollebergh W.A. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction 2012, 107:381-387.
34. van Gastel W.A., Maccabe J.H., Schubart C.D., Vreeker A., Tempelaar W., Kahn R.S., Boks M.P. Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults. Psychol. Med. 2013, 1-9.
35. van Laar W. Nationale Drug Monitor 2011 2011, Trimbos Institute, Utrecht, The Netherlands, (19-11-2012).
36. Verdoux H., Gindre C., Sorbara F., Tournier M., Swendsen J.D. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol. Med. 2003, 33:23-32.
37. Vleeschouwer M., Schubart C.D., Henquet C., Myin-Germeys I., van Gastel W.A., Hillegers M.H., van Os J.J., Boks M.P., Derks E.M. Does assessment type matter? A measurement invariance analysis of online and paper and pencil assessment of the Community Assessment of Psychic Experiences (CAPE). PLoS One 2014, 9:e84011.
38. Vreeker A., Schubart C.D., van Gastel W.A., Kahn R.S., Boks M.P. Advanced paternal age and vulnerability to psychotic-like experiences in the offspring. Schizophr. Res. 2013, 143:74-76.
39. Welham J., Scott J., Williams G., Najman J., Bor W., O'Callaghan M., McGrath J. Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study. Psychol. Med. 2009, 39:625-634.
40. Wu L.-T., Brady K.T., Mannelli P., Killeen T.K., NIDA AAPI Workgroup d Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J. Psychiatr. Res. 2014, 50:26-35.
41. Yung A.R., Nelson B., Baker K., Buckby J.A., Baksheev G., Cosgrave E.M. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust. N. Z. J. Psychiatry 2009, 43:118-128.